Abstract:Background: A hybrid molecule of different biologically active substances can improve affinity and efficiency compared to a standard drug. Hence based on this fact, we predict that a combination of fluorine, oxadiazole, sulfur, etc., may enhance α-glucosidase inhibition activity compared to a standard drug. Methods: A series of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives (2a-2i) were synthesized and characterized using spectroscopic techniques such as 1HNMR and LC-MS. In order to evaluate its bioactivity, in vitro α-amylase and α-glycosidase inhibitory activity were performed. In vivo study was carried using a genetic model, Drosophila melanogaster, for assessing the antihyperglycemic effects. Results: The compounds 2a-2i demonstrated α-amylase inhibitory activity in the range of IC50 = 40.00-80.00 μg/ml as compare to standard acarbose (IC50 = 34.71 μg/ml). Compounds 2a-2i demonstrated α-glucosidase inhibitory activity in the range of IC50 = 46.01-81.65 μg/ml as compared to standard acarbose (IC50 = 34.72 μg/ml). Docking studies on a target protein, N-terminal subunit of human Maltase-glucoamylase (PDB:2QMJ) was carried and the compounds were found to dock into the active site of the enzyme (Fig. 1). The predicted binding energies of the compounds were calculated. The in vitro studies indicate that compounds 2b and 2g had better activity among the synthesized compounds. Whereas in vivo study indicates that 2b, 2g, and 2i could lower glucose levels in the Drosophila, but then 17-30% reduced capacity than acarbose and may be overcome by adjusting their dosage. Conclusions: The in vitro and in vivo studies indicate that compounds 2b and 2g had better activity among the synthesized compounds. This study has recognized that compounds like 2b, 2g, and 2i may be considered potential candidates for further developing a novel class of antidiabetic agents.

2-Aminoresorcinol is a Potent Α-Glucosidase Inhibitor

A New Flavan-3-ol Lactone and Other Constituents from Euonymus Alatus with Inhibitory Activities on Α-Glucosidase and Differentiation of 3T3-L1 Cells.

Synthesis and Α-Glucosidase Inhibitory Activity Evaluation of N-substituted Aminomethyl-Β-d-glucopyranosides.

Α-Glucosidase Inhibitor from Chinese Aloes

Inhibitory potential of 4-hexylresorcinol against α-glucosidase and non-enzymatic glycation: Activity and mechanism

2β-Acetoxyferruginol derivatives as α-glucosidase inhibitors: Synthesis and biological evaluation

Hydroxycoumarin Derivatives: Novel and Potent Α-Glucosidase Inhibitors

Xanthone Sulfonamide Derivatives-A Novel Series of Α-Glucosidase Inhibitors with Different Inhibitory Types

Acetic Acid Derivatives of 3,4-Dihydro-2h-1,2,4-benzothiadiazine 1,1-Dioxide As a Novel Class of Potent Aldose Reductase Inhibitors.

Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors

Synthesis, Α-Glucosidase Inhibition and Molecular Docking Studies of Novel Thiazolidine-2,4-dione or Rhodanine Derivatives.

Synthesis of Rottlerone Analogues and Evaluation of Their α-Glucosidase and DPP-4 Dual Inhibitory and Glucose Consumption-Promoting Activity

1,2-Benzothiazine 1,1-Dioxide Carboxylate Derivatives As Novel Potent Inhibitors of Aldose Reductase

Synthesis of 6-Hydroxyaurone Analogues and Evaluation of Their Α-Glucosidase Inhibitory and Glucose Consumption-Promoting Activity: Development of Highly Active 5,6-Disubstituted Derivatives

Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1 H )-one as potent aldose reductase inhibitors with antioxidant activity

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity

Synthesis of 3-Acyloxyxanthone Derivatives As Α-Glucosidase Inhibitors: A Further Insight into the 3-Substituents’ Effect

Synthesis and Evaluation of the Α-Glucosidase Inhibitory Activity of 3-[4-(phenylsulfonamido)benzoyl]-2h-1-benzopyran-2-one Derivatives

Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and Α-Glucosidase As Potential Therapeutic Agents Against Diabetes Mellitus and Its Complications.

Synthesis, Molecular Docking and Α-Glucosidase Inhibition of 2-((5,6-Diphenyl-1,2,4-triazin-3-yl)thio)-n-arylacetamides.

Synthesis of Benzylidene Analogs of Oleanolic Acid As Potential Α-Glucosidase and Α-Amylase Inhibitors